To assess whether effects of an ciMSC-EV treatment were mainly attributed to prevention of neuronal cell loss and consecutive brain atrophy or may be also related to restauration of impaired cellular proliferation, we quantified the amount of Ki67-positive cells (Fig. 3, Suppl. This evidence concerns the gene MKI67 and Brain atrophy.